NASDAQ:AUPH (Aurinia Pharmaceuticals Inc.)
About AUPH
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Latest News

Top TSX Stocks
5 Cheap Canadian Stocks to Buy Now!

Investing
1 Industry Set to Explode in 2021 and Beyond

Top TSX Stocks
3 Cheap Stocks to Buy on the TSX Today

Coronavirus
Retire Early: Ignore Top Stocks and Buy This Instead!

Coronavirus
4 Canadian Stocks to Buy Right Now

Coronavirus
4 Canadian Stocks to Buy This Week

Coronavirus
My 3 Favourite TSX Stocks Today

Coronavirus
3 Dirt-Cheap TSX Stocks to Buy Now

Coronavirus
2 TSX Stocks Bay Street Expects Could Double in July!

Investing
3 Canadian Stocks to Buy Now at Dirt-Cheap Prices

Coronavirus
3 Undervalued Stocks That Are Screaming Buys Right Now

Coronavirus
3 Insanely Cheap Canadian Stocks to Buy in a Crazy-Expensive Market
1❯